Structure Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Coll Crespo Blas

Mar 18 20:45 ET

Structure Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hall Ashley

Mar 18 20:45 ET

Structure Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Ma Yingli

Mar 18 20:45 ET

Structure Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lin Xichen

Mar 18 20:45 ET

Structure Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Yoon Jun

Mar 18 20:45 ET

Structure Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Stevens Raymond C

Mar 18 20:45 ET

Structure Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Feb 27 17:25 ET

Structure Therapeutics | 10-K: FY2024 Annual Report

Feb 27 16:44 ET

Structure Therapeutics | 8-K: Structure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Highlights

Feb 27 16:39 ET

Structure Therapeutics | SCHEDULE 13G/A: Others

Feb 14 12:25 ET

Structure Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner FMR LLC

Feb 10 08:41 ET

Structure Therapeutics | SCHEDULE 13G: Others

Jan 13 16:12 ET

Structure Therapeutics | 8-K: Current report

Dec 17, 2024 16:20 ET

Structure Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(3.3%),Peter Kolchinsky(3.3%), etc.

Nov 14, 2024 17:51 ET

Structure Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Janus Henderson Group plc(6.9%)

Nov 14, 2024 10:31 ET

Structure Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avoro Capital Advisors LLC(0%),Behzad Aghazadeh(0%)

Nov 14, 2024 09:37 ET

Structure Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 13, 2024 22:32 ET

Structure Therapeutics | 8-K: Structure Therapeutics Reports Third Quarter 2024 Financial Results and Recent Highlights First patients dosed in Phase 2b ACCESS study of GSBR-1290 for obesity

Nov 13, 2024 16:17 ET

Structure Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Capital Research Global Investors(6.2%)

Nov 12, 2024 12:58 ET

Structure Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(14.999%),Abigail P. Johnson(14.999%)

Nov 12, 2024 10:40 ET